Par Formulations Private Limited

FDA Regulatory Profile

Par Formulations Private Limited appears in FDA public data with 1 recall, 0 510(k) clearances, 8 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0061-2023, Class II) was initiated on November 10, 2022.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
8
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0061-2023Class IIPhenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par PharmaceNovember 10, 2022